Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

38 recalls, newest first

Class II · Moderate risk

Umary Acid Hyaluronic

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.

Ongoing Chemical / undeclared Mxbbb D-0166-2025
Class II · Moderate risk

Trinity Gold Nutrition

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.

Ongoing Chemical / undeclared Trinity Gold Nutrition D-0042-2025
Class I · High risk

ZapMax Capsules

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Ongoing Chemical / undeclared Boulla LLC D-0086-2025
Class I · High risk

ZoomMax Capsules

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Ongoing Chemical / undeclared Boulla LLC D-0085-2025
Class I · High risk

PeakMax Capsules

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Ongoing Chemical / undeclared Boulla LLC D-0084-2025
Class I · High risk

VitalityXtra Capsules

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Ongoing Chemical / undeclared Boulla LLC D-0083-2025
Class II · Moderate risk

First Aid Antiseptic Ointment

Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.

Ongoing Chemical / undeclared Zhejiang Jingwei Pharmaceutical Co., Ltd. D-0013-2025
Class I · High risk

Umary Acido Hialuronico

Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Ongoing Chemical / undeclared Main Products INC D-0626-2024
Class I · High risk

Umary Acido Hialuronico

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Ongoing Chemical / undeclared SoloVital D-0620-2024
Class I · High risk

Gold Hard Steel Plus Liquid

Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.

Ongoing Chemical / undeclared Supercore Products Group Inc. D-0004-2025
Class I · High risk

Alcoholada Gel

Chemical Contamination: Product manufactured with ethanol API that contains methanol

Ongoing Chemical / undeclared Aruba Aloe Balm N.V. D-0459-2024
Class I · High risk

Honey Manuka Bunny Love

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0458-2024
Class I · High risk

The GOAT SUBLINGUAL STRIP

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0456-2024
Class I · High risk

libigrow RED DRAGON+

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0454-2024

Recalls by year